vTv Therapeutics (VTVT)
NASDAQ:VTVT
Want to see VTVT full AI Analyst Report?
VTVT Analyst Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
VTVT Stock 12 Month Forecast
Average Price Target
$53.00
▲(39.03% Upside)
| Highest Price Target$67.00 | Average Price Target$53.00 | Lowest Price Target$44.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TD Cowen
$67
Buy
75.76%
Upside
Reiterated
05/14/26
H.C. Wainwright
$47→$45
Buy
18.05%
Upside
Reiterated
05/14/26
Alliance Global Partners
$55
Buy
44.28%
Upside
Reiterated
05/14/26
BTIG
$49
Buy
28.54%
Upside
Reiterated
05/13/26
Roth MKM
$58
Buy
52.15%
Upside
Reiterated
05/13/26
Evercore ISI
$44
Buy
15.42%
Upside
Initiated
03/12/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
$67
Buy
75.76%
Upside
Reiterated
05/14/26
H.C. Wainwright
$47→$45
Buy
18.05%
Upside
Reiterated
05/14/26
Alliance Global Partners
$55
Buy
44.28%
Upside
Reiterated
05/14/26
BTIG
$49
Buy
28.54%
Upside
Reiterated
05/13/26
Roth MKM
$58
Buy
52.15%
Upside
Reiterated
05/13/26
Evercore ISI
$44
Buy
15.42%
Upside
Initiated
03/12/26
Best Analysts Covering vTv Therapeutics
3 Months
Success Rate
5/9 ratings generated profit
Average Return
+18.31%
Copying Emily Bodnar's trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +18.31% per trade.
1 Year
Success Rate
8/9 ratings generated profit
Average Return
+60.74%
Copying Emily Bodnar's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +60.74% per trade.
2 Years
Success Rate
8/9 ratings generated profit
Average Return
+60.72%
Copying Emily Bodnar's trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +60.72% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
VTVT Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
3
3
6
4
7
Buy
5
5
6
4
4
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
8
12
8
11
Each month's total comprises the sum of three months' worth of ratings.
VTVT Financial Forecast
VTVT Stock Forecast FAQ
What is VTVT’s average 12-month price target, according to analysts?
Based on analyst ratings, vTv Therapeutics’s 12-month average price target is 53.00.
What is VTVT’s upside potential, based on the analysts’ average price target?
vTv Therapeutics has 39.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VTVT a Buy, Sell or Hold?
vTv Therapeutics has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
What is vTv Therapeutics’s price target?
The average price target for vTv Therapeutics is 53.00. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $67.00 ,the lowest forecast is $44.00. The average price target represents 39.03% Increase from the current price of $38.12.
The highest analyst price target is $67.00 ,the lowest forecast is $44.00. The average price target represents 39.03% Increase from the current price of $38.12.
What do analysts say about vTv Therapeutics?
vTv Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of VTVT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.